Introduction {#s1}
============

Periodontal diseases are a set of highly prevalent inflammatory diseases that affect the tissues (gingiva, periodontal ligaments and alveolar bone) that support the teeth ([@B5]). In the early stage of gingivitis, only the gums are affected. In the late stage of chronic periodontitis, bone loss occurs. Genetic, environmental, and behavioral factors contribute to the development of periodontal diseases ([@B31]; [@B27]; [@B35]; [@B40]; [@B14]). Periodontal diseases could produce a reciprocal impact on general health and other organ systems, and may contribute to the development and progression of diabetes, cardiovascular diseases, gastrointestinal tract diseases, and kidney diseases ([@B2]; [@B32]; [@B6]).

5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter that regulates the function of the central nervous system ([@B30]) as well as other physiological processes ([@B9]). Re-uptake by the 5-HT transporter (5-HTT or SLC6A4) is a major mechanism that removes 5-HT from the synaptic cleft after release. The human gene is located on chromosome 17q11.2 and consists of 15 exons. The gene occurs in polymorphic forms, which in turn affects 5-HTT expression levels, and ultimately 5-HT concentration ([@B23]).

The *5-HTT* gene is implicated in complex behavioral traits and a variety of psychiatric diseases ([@B11]; [@B7]; [@B41]). Several previous studies associate periodontal diseases with psychological stress and anxiety ([@B17]; [@B18]; [@B34]; [@B12]). Periodontal disease occurrence is affected by both genetic and environmental factors ([@B36]; [@B25]; [@B13]). 5-HT is also implicated in bone metabolism ([@B15]), and could control periodontitis-induced alveolar bone loss ([@B16]). We therefore speculate that 5-HT neurotransmission is implicated in periodontal diseases and thus conducted a case-control study to examine the potential association between chronic periodontitis with single nucleotide polymorphisms (SNPs) (rs6354 and rs12449783) of the *5-HTT* gene.

Materials and Methods {#s2}
=====================

Study Subjects {#s2_1}
--------------

This study was approved by the Ethics Committee of the Institute of Evidence-Based Medicine and Knowledge Translation, Henan University. Sample collection conformed to the ethics criteria of national human genome research. All subjects provided written informed consent prior to study commencement.

This study included a total of 120 patients with chronic periodontitis (68 women and 52 men; age range: 36 to 57 years) receiving medical care as outpatients at Henan University Hospital during a period from July 2013 to July 2015. Subjects with diabetes or cardiovascular diseases were excluded. The diagnosis was established by the same dentist using the 1999 International Classification of the Periodontal Disease and Conditions ([@B1]). The controls included 125 healthy individuals (72 women and 53 men, aged range: 33 to 64 years) receiving an annual physical check-up at Henan University Hospital during the same period. Controls had no oral diseases, systemic diseases or history of periodontal disease treatment. One-hundred-and-twenty-five healthy individuals (72 women and 53 men, aged between 33 and 64) were included. Both patients and the control subjects received a complete intra-oral examination to assess supra-gingival plaque accumulation, gingival recession, bleeding on probing (BOP), probing pocket depth (PPD), and clinical attachment loss (CAL). Specific criteria for chronic periodontitis included: PPD \>5 mm, CAL \>4 mm, gingival recession and tooth mobility. Control subjects had no gingival recession, CAL or PPD \>3 mm.

Sample Collection {#s2_2}
-----------------

Oral mucosa was obtained using a sterile dentiscalprum and stored at −20°C prior to genomic DNA extraction using a phenol-chloroform method.

Genotyping {#s2_3}
----------

Primers were designed with Primer Premier 5.0, and synthesized by Sangon Biotech (Shanghai, China) ([**Table 1**](#T1){ref-type="table"}). PCR amplification was performed in a total volume of 25 µl with an ice bath, including 5 µl 10 × Buffer, 2 µl template DNA, 1 µl upstream primer, 1 µl downstream primer, 0.5 µl Taq DNA polymerase, 2 µl dNTP, and 13.5 µl deionized sterile water. The quality of the PCR products was examined using 1% agarose gel electrophoresis.

###### 

Primer sequences for *5-HTT* gene rs6354 and rs12449783 polymorphisms.

  SNP          Primer sequence              
  ------------ ---------------------------- ----------------------------
  rs6354       Upstream                     5′-CCTGCACACTCTTCTCCCTA-3′
  Downstream   5′-TTTCTGCGTTCCCATTATGC-3′   
  rs12449783   Upstream                     5′-AGTAAGCGGTGGCTCACTCC-3′
  Downstream   5′-TGCCCATGTGCATGTTTAAT-3′   

PCR products were digested at 37°C overnight with *HpaII* (rs6354) and *MluCI* (rs12449783), respectively. A total volume of 10 µl digestion system contained 2 µl 10 × Buffer, 0.2 µl 100 × BSA, 0.5 µl enzyme, 5 µl PCR products, and 2.3 µl deionized sterile water. DNA fragments were separated using 2% agarose gel electrophoresis and visualized under UV light.

Statistical Analysis {#s2_4}
--------------------

All statistical analyses were conducted using PASW statistics 18.0 software. Conformity of genotype distribution to Hardy--Weinberg equilibrium (HWE) was examined in the controls with Haploview. A χ^2^ test was used to compare genotype and allele distribution between the cases and controls. Association of *5-HTT* gene polymorphisms with chronic periodontitis is presented as odds ratios (ORs) and 95% confidence intervals (CIs), and adjusted for age, sex and smoking status. A subgroup analysis was performed based on sex. Statistical significance was set at P \< 0.05 (two-sided).

Results {#s3}
=======

Demographic and Clinical Characteristics {#s3_1}
----------------------------------------

The obtained 120 patients included 68 women and 52 men with an age range from 36 to 57. And the mean age of the patients and controls was 45.32 ± 10.59 and 46.51 ± 11.86 years, respectively ([**Table 2**](#T2){ref-type="table"}). The female to male ratio was 1.31 and 1.36 in the cases and controls, respectively. More subjects were smokers in the cases than in controls (*P* = 0.001).

###### 

Demographic and clinical characteristics of the cases and controls.

                     Case (*n* = 120)   Control (*n* = 125)   *P*
  ------------------ ------------------ --------------------- ---------
  Age (year)         45.32 ± 10.59      46.51 ± 11.86         0.463
  Gender (%)                                                  0.883
  Male               52 (43.33)         53 (42.40)            
  Female             68 (56.67)         72 (57.60)            
  Smoking (%)                                                 0.001
  Current and ever   41 (34.17)         19 (15.20)            
  Never              79 (65.83)         106 (84.80)           
  BOP (% site)       83.55 ± 19.64      47.96 ± 7.1           \<0.001
  PPD (mm)           5.86 ± 0.67        1.59 ± 0.48           \<0.001
  CAL (mm)           6.32 ± 0.81        0.0                   \<0.001

BOP, bleeding on probing; PPD, probing pocket depth; CAL, clinical attachment loss.

HWE Test {#s3_2}
--------

Genotype distribution of the gene polymorphisms rs6354 and rs12449783 in the control group conformed to HWE (*P* \> 0.05, [**Table 3**](#T3){ref-type="table"}).

###### 

Genotype and allele distributions of rs6354 and rs12449783 polymorphisms in the cases and controls.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                 Case\           Control\        *P* ~HWE~   *χ* ^2^   *P*     OR (95% CI)            *P* [*^a^*](#fnT3_1){ref-type="table-fn"}   **OR[^a^](#fnT3_1){ref-type="table-fn"} (95% CI)**
                 *n* = 120 (%)   *n* = 125 (%)                                                                                                    
  -------------- --------------- --------------- ----------- --------- ------- ---------------------- ------------------------------------------- ----------------------------------------------------
  rs6354                                         0.194                                                                                            

  AA             81(67.50)       99(79.20)                   −         −       1                                                                  

  AC             38(31.67)       26(20.80)                   3.905     0.048   1.786 (1.001--3.187)   0.034                                       1.910 (1.049--3.476)

  CC             1(0.83)         0(0.00)                     1.214     0.271   0.988 (0.964--1.012)   −                                           −

  AC+CC          39              26                          4.300     0.038   1.833 (1.030--3.263)   0.021                                       2.026 (1.115--3.680)

  A              200(83.33)      224(89.60)                  −         −       1                                                                  

  C              40(16.67)       26(10.40)                   4.126     0.042   1.723 (1.015--2.925)   0.023                                       1.875 (1.089--3.228)

  rs12449783                                     0.799                                                                                            

  AA             10(8.33)        7(5.60)                     −         −       1                                                                  

  AC             36(30.00)       43(34.40)                   0.985     0.321   0.586 (0.203--1.696)   0.446                                       0.652 (0.217--1.958)

  CC             74(61.67)       75(60.00)                   0.512     0.474   0.691 (0.250--1.911)   0.714                                       0.821 (0.285--2.362)

  AC+CC          110             118                         0.708     0.400   0.653 (0.240--1.774)   0.597                                       0.756 (0.268--2.132)

  CC vs. AA+AC   46              50                          0.071     0.789   1.072 (0.642--1.792)   0.564                                       1.170 (0.687--1.991)

  A              56(23.33)       57(22.80)                   −         −       1                                                                  

  C              184(76.67)      193(77.20)                  0.020     0.889   0.970 (0.637--1.478)   0.803                                       1.057 (0.684--1.633)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HWE, Hardy--Weinberg equilibrium; OR, odds ratio; CI, confidence interval.

the values of P and OR were adjusted by age, gender and smoking.

Genotype and Allele Distributions {#s3_3}
---------------------------------

The CC genotype of rs6354 was not detected in the healthy controls, and in only 1 (0.83%) of the cases ([**Table 3**](#T3){ref-type="table"} **and** [**Figure 1**](#f1){ref-type="fig"}). The frequency of the AA genotype of rs6354 did not differ between the cases and controls (67.50% vs. 79.20%). The frequency AC genotype of rs6354 was significantly higher in the cases (31.67% vs. 20.80% in the controls; *P* = 0.048). OR was 1.786 (95%CI = 1.001--3.187). An analysis using the dominant model revealed a higher AC+CC genotype frequency in the cases (OR = 1.833, 95%CI = 1.030--3.263, *P* = 0.038). After adjustment for age, sex and smoking, the association remained significant (AC vs. AA: adjusted OR = 1.910, 95%CI = 1.049--3.476, *P* = 0.034; AC+CC: adjusted OR = 2.026, 95%CI = 1.115--3.680, *P* = 0.016). The C allele frequency was higher in the cases (16.67% vs. 10.40%; P = 0.042), with an OR at 1.723 (95%CI = 1.015--2.925). The results were similar after adjustment for clinical parameters (adjusted OR = 1.875, 95%CI = 1.089--3.228, *P* = 0.023).

![The distributions of *5-HTT* gene polymorphisms rs6354 **(A)** and rs12449783 **(B)** in patients with chronic periodontitis and healthy control subjects. \*\*P \< 0.05, NS, not significant.](fgene-10-00706-g001){#f1}

The rs12449783 genotype did not differ between the cases and controls ([**Table 3**](#T3){ref-type="table"}): 8.33% vs. 5.60% for AA, 30.00% vs. 34.40% for AC, and 61.67% vs. 60.00% for CC.

The subgroup analysis that included only women showed a higher frequency of the AC genotype of rs6354 in the cases (38.24% vs. 22.22%, *P* = 0.039), with an OR at 2.167 (95%CI = 1.034--4.542) ([**Figure 2**](#f2){ref-type="fig"} and [**Table 4**](#T4){ref-type="table"}). No difference was detected between the cases and the controls in the male population in both rs6354 and rs12449783 ([**Figure 2**](#f2){ref-type="fig"} and [**Table 4**](#T4){ref-type="table"}).

![Subgroup analysis of genotype and allele distributions of *5-HTT* gene polymorphisms rs6354 **(A, B)** and rs12449783 **(C, D)**. \*\*P \< 0.05, NS, not significant.](fgene-10-00706-g002){#f2}

###### 

Genotype and allele distributions of rs6354 and rs12449783 polymorphisms: subgroup analysis based on sex.

  -------------------------------------------------------------------------------------
                   Case\          Control\       *χ*²    *P*     OR(95% CI)
                   *n* = 120      *n = 125*                      
  ---------------- -------------- -------------- ------- ------- ----------------------
  **rs6354**                                                     

  Females          *n* = 68 (%)   *n* = 72 (%)                   

   AA              42 (61.76)     56 (77.78)     --      --      1.000

   AC              26 (38.24)     16 (22.22)     4.270   0.039   2.167 (1.034--4.542)

   CC              0 (0.00)       0 (0.00)       --      --      --

   A               110 (80.88)    128 (88.89)    --      --      1.000

   C               26 (19.12)     16 (11.11)     3.517   0.061   1.891 (0.965--3.706)

  Males            *n* = 52 (%)   *n* = 53 (%)                   

   AA              39 (75.00)     43 (81.13)     \-      \-      1.000

   AC              12 (23.08)     10 (18.87)     0.339   0.561   1.323 (0.515--3.402)

   CC              1 (1.92)       0 (0.00)       1.088   0.297   1.026 (0.976--1.078)

   A               90 (86.54)     96 (90.57)     --      --      1.000

   C               14 (13.46)     10 (9.43)      0.841   0.359   1.493 (0.631--3.531)

  **rs12449783**                                                 

  Females          *n* = 68 (%)   *n* = 72 (%)                   

   AA              6 (8.82)       4 (5.56)       --      --      1.000

   AC              20 (29.41)     26 (36.11)     0.901   0.342   0.513 (0.127--2.065)

   CC              42 (61.76)     42 (58.33)     0.358   0.550   0.667 (0.175--2.535)

   A               32 (23.53)     34 (23.61)     \-      \-      1.000

   C               104 (76.47)    110 (76.39)    0.000   0.987   1.005 (0.578--1.745)

  Males            *n* = 52 (%)   *n* = 53 (%)                   

   AA              4 (7.69)       3 (5.66)       --      --      1.000

   AC              16 (30.77)     17 (32.08)     0.173   0.677   0.706 (0.136--3.658)

   CC              32 (61.54)     33 (62.26)     0.158   0.691   0.727 (0.151--3.510)

   A               24 (23.08)     23 (21.70)     --      --      1.000

   C               80 (76.92)     83 (78.30)     0.057   0.811   0.924 (0.483--1.768)
  -------------------------------------------------------------------------------------

The LD Analysis of rs6354 and rs12449783 {#s3_4}
----------------------------------------

Significant LD of rs6354 and rs12449783 was identified (D' = 0.71, r2 = 0.331). The C-C haplotype was associated with periodontitis (OR = 2.372, 95%CI = 1.154--4.875, *P* = 0.016). Detailed haplotype information is shown in [**Table 5**](#T5){ref-type="table"}.

###### 

Haplotype analysis of rs6354 and rs12449783 polymorphisms.

  Rs6354-rs12449783   Haplotype (%)   *χ*²          *P*     OR (95%CI)   
  ------------------- --------------- ------------- ------- ------------ ----------------------
  A-C                 159 (66.25)     181 (72.40)   --      --           Ref.
  C-A                 15 (6.25)       14 (5.60)     0.264   0.608        1.220 (0.571--2.605)
  A-A                 41 (17.08)      43 (17.20)    0.113   0.737        1.085 (0.673--1.750)
  C-C                 25 (10.42)      12 (4.80)     5.780   0.016        2.372 (1.154--4.875)

Discussion {#s4}
==========

Periodontal diseases contribute to the development and progression of many other diseases ([@B32]). The importance of prevention, early diagnosis and treatment of periodontal diseases is thus far beyond the scope of dentistry.

Many factors, including oral hygiene, smoking, stress and anxiety, obesity and diabetes, contribute to the etiology of periodontal diseases ([@B36]; [@B8]). Dental plaque is clearly an early step in the development of periodontal diseases, but many other factors are implicated in the progression of gingivitis to chronic periodontitis. Numerous studies have shown that susceptibility to periodontal diseases are affected by the polymorphisms of many genes, including interleukin-1 (*IL-1*) ([@B4]), tumor necrosis factor-α (*TNF-α*) ([@B21]), transforming growth factor-beta (TGFβ) and 5-HTT ([@B33]).

5-HTT is a critical part of 5-HT transmission. Many studies have implicated in the etiology of neuropsychiatric disorders ([@B26]; [@B3]). Recent research also implicated 5-HT in the pathogenesis of autoimmune and chronic inflammatory diseases ([@B39]). Polymorphisms of the gene could alter the expression and function of ([@B20]). Two polymorphic regions of the gene have been identified: a 44bp insertion-deletion in the promoter region (*LPR*) and a 17bp variable number of tandem repeat (VNTR) in the second intron ([@B28]; [@B22]). The long (L) allele of LPR polymorphism increases 5-HT re-uptake ([@B19]), whereas the short (S) allele decreases the transcriptional efficiency of 5-HTT ([@B29]). Multiple lines of evidence suggests that psychological factors also contribute in susceptibility to periodontal diseases ([@B17]; [@B18]; [@B34]; [@B12]). A study by Costa et al. suggests that*t*he *5-HTT LPR* polymorphism is a risk of aggressive periodontitis in a Brazilian population ([@B10]). No studies have examined the potential association between polymorphisms and periodontal diseases in a Chinese population.

The current study confirms the association between *5-HTT* polymorphism and chronic periodontitis in the Chinese population. Specifically, the AC genotype, AC+CC genotype and C allele of the rs6354 polymorphism were more frequent in the subjects than in the healthy controls. Subgroup analysis suggested that women carrying the AC genotype of rs6354 have a higher risk of chronic periodontitis than women carrying other genotypes. A study by Su et al. indicated that rs6354 increases the risk of depressive symptoms ([@B37]). Considering the notion that depression represents a risk factor of periodontal diseases ([@B24]; [@B42]; [@B38]), the association between rs6354 polymorphism and chronic periodontitis is reasonable. We did not find a significant association between the rs12449783 *5-HTT* polymorphism, but did show LD between rs6354 and rs12449783 and an increased risk of chronic periodontitis in subjects carrying the C-C haplotype C-C. The interaction between the two *5-HTT* SNPs requires further investigation.

The current study has several limitations. First, the sample size was relatively small for conducting subgroup analysis. Second, all study subjects were of Chinese Han ethnicity; whether the results could be extrapolated into other ethnic groups is unknown. Third, the results were adjusted only by age, sex and smoking status. Future studies with a larger sample size are needed to verify our findings.

In conclusion, *5-HTT* rs6354 but not rs12449783 polymorphism is associated with a susceptibility to chronic periodontitis in the Chinese Han population. The interaction between the two SNPs also seems to be associated with chronic periodontitis.
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